Ilya Gluhovsky

Sun Microsystems, Inc. provides network computing infrastructure solutions. It offers its solutions under the Java technology platform, Solaris Operating System, MySQL database management system, Sun StorageTek storage solutions, and UltraSPARC processor brands. The company also develops networking computing products and technologies which include servers, storage, open source software, tools, and training. The company provides solutions to the social networking, entertainment, financial services, manufacturing, healthcare, retail, news, energy, and engineering companies. The company was founded in 1982 and is headquartered in Santa Clara, CA.

Yahoo!, Inc. is a guide to digital information discovery, focused on informing, connecting, and entertaining users through its search, communications, and digital content products. It operates through the following geographical segments: Americas; Europe, Middle East, and Africa (EMEA); and Asia Pacific. The company was founded by Jerry Chih-Yuan Yang and David Filo in January 1994 and is headquartered in Sunnyvale, CA.

Digg, Inc. operates a content curation media that showcases content trending on social media. The company was founded by Jay Steven Adelson and Robert Kevin Rose in November 2004 and is headquartered in New York, NY.

Ancestry.com, Inc. provides online network services for connecting families. The company was founded in 1983 and is headquartered in Lehi, UT.

Part of International Business Machines Corp., IBM Watson Research Center provides business analytics technology that works across the health landscape, from payers and providers to government & life science. The company is based in Yorktown Heights, NY.

GetGoing, Inc. provides air travelling and related services. It engages in providing air transportation services. The company was founded by Ilya Gluhovsky, Alek Strygin, Alek Vernitsky and Eli Rosenberg in November 2011 and is headquartered in San Francisco, CA.

Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA. The company’s lead product, reSET, for the treatment of substance use disorder, was the first PDT to receive marketing authorization from the FDA to treat disease. Its second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. Pear's third product, Somryst for the treatment of chronic insomnia, was the first PDT submitted through the FDA's traditional 510(k) pathway while simultaneously reviewed through the FDA's Software Precertification Pilot Program. The company was founded on December 1, 2020 and is headquartered in Boston, MA.